Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05786014 · ClinicalTrials.gov registry record · NA
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05786014 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 24 participants.
The verdict
NCT05786014, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, inflammatory responses, and quality of life.
Interventions
- BEHAVIORAL High Intensity Interval Exercise
- BEHAVIORAL Moderate Intensity Walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05786014
The ClinicalTrials.gov registry entry for NCT05786014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Intensity Interval Exercise is the first listed.
NCT05786014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05786014 about?
NCT05786014 is a clinical study titled "The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies". The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, inflammatory responses, and quality of life.
What is the current status of trial NCT05786014?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-04-01. Estimated completion is 2024-08-26.
What interventions are being tested in trial NCT05786014?
The interventions under investigation include: High Intensity Interval Exercise (BEHAVIORAL), Moderate Intensity Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT05786014?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.